Compile Data Set for Download or QSAR
Report error Found 10 Enz. Inhib. hit(s) with all data for entry = 12632
TargetTranscriptional enhancer factor TEF-1 [209-426](Human)
Merck Patent

US Patent
LigandPNGBDBM716243(N-[2-(1-methyl-2,6-dioxopiperidin-3-yl)-1,3-dioxo-...)
Affinity DataKd:  980nMAssay Description:The kinetic and affinity parameters of protein-exemplary compound interactions were evaluated by SPR. hsTEAD1 (209-426) was immobilized onto a CM7 (S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
Go to US Patent

TargetTranscriptional enhancer factor TEF-1 [209-426](Human)
Merck Patent

US Patent
LigandPNGBDBM716327(N-(14-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-...)
Affinity DataKd:  3.01E+3nMAssay Description:The kinetic and affinity parameters of protein-exemplary compound interactions were evaluated by SPR. hsTEAD1 (209-426) was immobilized onto a CM7 (S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
Go to US Patent

TargetTranscriptional enhancer factor TEF-1 [209-426](Human)
Merck Patent

US Patent
LigandPNGBDBM716328(4-{[2-(2,6-dioxopiperidin-3-yl)-1-oxo-2,3-dihydro-...)
Affinity DataKd:  482nMAssay Description:The kinetic and affinity parameters of protein-exemplary compound interactions were evaluated by SPR. hsTEAD1 (209-426) was immobilized onto a CM7 (S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
Go to US Patent

TargetTranscriptional enhancer factor TEF-1 [209-426](Human)
Merck Patent

US Patent
LigandPNGBDBM716329(5-{[2-(2,6-dioxopiperidin-3-yl)-1-oxo-2,3-dihydro-...)
Affinity DataKd:  970nMAssay Description:The kinetic and affinity parameters of protein-exemplary compound interactions were evaluated by SPR. hsTEAD1 (209-426) was immobilized onto a CM7 (S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
Go to US Patent

TargetTranscriptional enhancer factor TEF-1 [209-426](Human)
Merck Patent

US Patent
LigandPNGBDBM716330(7-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihy...)
Affinity DataKd:  1.40E+3nMAssay Description:The kinetic and affinity parameters of protein-exemplary compound interactions were evaluated by SPR. hsTEAD1 (209-426) was immobilized onto a CM7 (S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
Go to US Patent

TargetTranscriptional enhancer factor TEF-1 [209-426](Human)
Merck Patent

US Patent
LigandPNGBDBM716331(2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihy...)
Affinity DataKd:  1.90E+3nMAssay Description:The kinetic and affinity parameters of protein-exemplary compound interactions were evaluated by SPR. hsTEAD1 (209-426) was immobilized onto a CM7 (S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
Go to US Patent

TargetTranscriptional enhancer factor TEF-1 [209-426](Human)
Merck Patent

US Patent
LigandPNGBDBM716332(N-[(2S)-1-[(2S,4R)-4-hydroxy-2-({[4-(4-methyl-1,3-...)
Affinity DataKd:  320nMAssay Description:The kinetic and affinity parameters of protein-exemplary compound interactions were evaluated by SPR. hsTEAD1 (209-426) was immobilized onto a CM7 (S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
Go to US Patent

TargetTranscriptional enhancer factor TEF-1 [209-426](Human)
Merck Patent

US Patent
LigandPNGBDBM716333(N-[(2S)-1-[(2S,4R)-4-hydroxy-2-({[4-(4-methyl-1,3-...)
Affinity DataKd:  320nMAssay Description:The kinetic and affinity parameters of protein-exemplary compound interactions were evaluated by SPR. hsTEAD1 (209-426) was immobilized onto a CM7 (S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
Go to US Patent

TargetTranscriptional enhancer factor TEF-1 [209-426](Human)
Merck Patent

US Patent
LigandPNGBDBM716334(2-{2-[2-({[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2...)
Affinity DataKd:  1.52E+3nMAssay Description:The kinetic and affinity parameters of protein-exemplary compound interactions were evaluated by SPR. hsTEAD1 (209-426) was immobilized onto a CM7 (S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
Go to US Patent

TargetTranscriptional enhancer factor TEF-1 [209-426](Human)
Merck Patent

US Patent
LigandPNGBDBM716335(N'-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihy...)
Affinity DataKd:  1.87E+3nMAssay Description:The kinetic and affinity parameters of protein-exemplary compound interactions were evaluated by SPR. hsTEAD1 (209-426) was immobilized onto a CM7 (S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
Go to US Patent